News

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...
New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...
Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
To O’Sullivan, it amounts to a culture of overdiagnosis, where we may place more importance on labels than healthcare, ...
Pharma’s next big leap won’t come from the lab. It’ll come from outside the lab, where the rules of narrative, attention, and ...
A doctor has pleaded guilty to illegally supplying ketamine to Matthew Perry before the overdose death of the ‘Friends’ star.
The first step in reducing the risk of artificial intelligence-associated psychosis is to correct misunderstandings about ...
Advocates for community violence intervention programs say it saves lives. Data shows success, too. But funding for these ...
The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who ...
With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug review and speed up approval is not here yet.
Despite ambitions to streamline regulatory review, FDA’s Elsa platform has been prone to hallucinations, prompting internal scrutiny and questions about AI reliability and governance.